Literature DB >> 1540180

Biological activities of rabbit antibodies against synthetic human thyrotropin receptor peptides representing thyrotropin binding regions.

S Sakata1, T Ogawa, I Matsui, T Manshouri, M Z Atassi.   

Abstract

Recently, we have shown that the thyrotropin (TSH) binding regions of human thyrotropin receptor (TSHR) reside in two areas within residues 12-44 and 308-344. Serial antisera were raised against four overlapping synthetic peptides representing these two regions of TSHR (peptides 12-30, 24-44, 308-328, and 324-344) and were investigated for their ability to stimulate or block the cultured porcine thyroid cells. In addition, serum concentrations of triiodothyronine (T3) and thyroxine (T4) in serial sera obtained from each rabbit were examined. It was shown that residues of 12-30 and 324-344 of TSHR, respectively, are the site (at least a part of the site) where stimulating (TSAb) and blocking type (TSBAb) immunoglobulins are directed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540180     DOI: 10.1016/0006-291x(92)91884-s

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.

Authors:  G Carayanniotis; G C Huang; L B Nicholson; T Scott; P Allain; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

2.  Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism.

Authors:  T Ogura; Y Mimura; F Otsuka; M Kishida; K Yokota; J Suzuki; A Nagai; S Hirakawa; H Makino; K Tobe
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

3.  Immunogenicity of a unique region of the human thyrotropin receptor.

Authors:  E V Nagy; H B Burch; Y G Lukes; F E Carr; S Kosugi; L D Kohn; K D Burman
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.